David Owen
Neurology with Special Qualifications in Child Neurology · Dallas, TXNPI 1386621365
Payments from drug & device makers
Across 162 payments — averaging $25.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$850
- Greenwich Biosciences, Inc.$691
- Eisai Inc.$576
- Tris Pharma Inc$449
- UCB, Inc.$393
- Sunovion Pharmaceuticals Inc.$286
- plus $962 from 14 others
What the payments were for
- Speaking & faculty fees$50012%
- Food & beverage$3,70688%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $850 |
| Greenwich Biosciences, Inc. | 25 | $691 |
| Eisai Inc. | 19 | $576 |
| Tris Pharma Inc | 14 | $449 |
| UCB, Inc. | 18 | $393 |
| Sunovion Pharmaceuticals Inc. | 17 | $286 |
| SK Life Science, Inc. | 9 | $258 |
| Aquestive Therapeutics, Inc. | 9 | $145 |
| Neos Therapeutics, LP | 5 | $99 |
| Neurelis, Inc. | 6 | $98 |
| Novartis | 5 | $82 |
| Vertical Pharmaceuticals, LLC | 3 | $63 |
| Livanova USA, Inc. | 2 | $42 |
| AbbVie(2 entities) | 2 | $40 |
| Aprecia Pharmaceuticals, LLC | 3 | $36 |
| Shire North American Group Inc | 2 | $29 |
| Biomarin Pharmaceutical Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXTELLAR XR$601
- Dyanavel XR$237
- Fycompa$212
- Quillichew ER$115
- Quillivant XR$115
How this compares
$4,206 in reported general payments places this provider in the 60th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Dallas
- Roy EltermanDallas$5.9M
- Charuta JoshiDallas$902K
- Raphael SchiffmannDallas$643K
- Kaitlin BatleyDallas$540K
- Steven SparaganaDallas$224K
- Cynthia WangDallas$135K
- Deepa SirsiDallas$112K
- Mauricio Delgado-AyalaDallas$88K
- Eric RemsterDallas$64K
- Daniel GossettDallas$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.